Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Category: Diabetes

522-P: Utilization of Personal Continuous Glucose Monitoring (CGM) Systems in the Inpatient Setting

July 16, 2025 by sugaradmin

Introduction and Objective: This pilot study sought to compare glucose outcomes and provider insulin dosing confidence in individuals using personal CGM while in the hospital compared to those receiving point of care blood glucose (POC BG) monitoring only.Methods: Hospitalized individuals followed by the diabetes service and expected to be discharged on insulin were included. Diabetes […]

Read More
DiabetesLeave a Comment on 522-P: Utilization of Personal Continuous Glucose Monitoring (CGM) Systems in the Inpatient Setting

652-P: Effectiveness of a Digital Lifestyle Intervention for Glycemic Control in People with Type 2 Diabetes

July 16, 2025 by sugaradmin

Introduction and Objective: This study aims to evaluate the effectiveness of a digital lifestyle-based interventional program, developed by us, [D-LITE (Diabetes- Lifestyle Intervention for Therapeutic Enhancement)], on metabolic control in individuals with diabetes.Methods: An online diabetes management program utilizing a WhatsApp-based model facilitated continuous and collaborative care among patient, a dietitian, and physicians. The program […]

Read More
DiabetesLeave a Comment on 652-P: Effectiveness of a Digital Lifestyle Intervention for Glycemic Control in People with Type 2 Diabetes

521-P: Greater Participation in Diabetes Management Coaching Program Improves Glycemic Control and Diabetes Distress

July 16, 2025 by sugaradmin

Introduction and Objective: Virtual diabetes management platforms can be used to improve glycemic control for people with diabetes. The objective of this study was to evaluate the effectiveness of the Diabetes Care Management coaching program in the Wellworks for You© (WW) chronic disease management virtual platform.Methods: A cohort of people with diabetes enrolled in the […]

Read More
DiabetesLeave a Comment on 521-P: Greater Participation in Diabetes Management Coaching Program Improves Glycemic Control and Diabetes Distress

64-PUB: Comparison of Body Mass Index and Bioelectric Impedance Analysis for Clinical Assessment of Obesity

July 16, 2025 by sugaradmin

Introduction and Objective: Body mass index (BMI), weight adjusted for height, is an imprecise tool for the diagnosis of obesity. Body composition assessment with bioelectric impedance analysis (BIA) scales estimate fat mass and % adiposity, offering a more precise diagnosis of obesity. The objective of this project was to compare the use of BMI and […]

Read More
DiabetesLeave a Comment on 64-PUB: Comparison of Body Mass Index and Bioelectric Impedance Analysis for Clinical Assessment of Obesity

520-P: School Day Disruptions in Type 1 Diabetes (T1D) Management—Early Experiences from the School-Partnered Collaborative Care (SPACE) Study Highlight an Unmet T1D Education Need

July 16, 2025 by sugaradmin

Introduction and Objective: T1D management may require frequent interventions which disrupt the school day, though the missed class time and impact on students are not described. We aimed to determine the frequency, duration, and type of school disruptions for students with T1D.Methods: We analyzed data for 16 children (age 9.0±1.8 years, 62% female, 31% public […]

Read More
DiabetesLeave a Comment on 520-P: School Day Disruptions in Type 1 Diabetes (T1D) Management—Early Experiences from the School-Partnered Collaborative Care (SPACE) Study Highlight an Unmet T1D Education Need

1057-P: Cost Analysis of Freestyle Libre Systems in Patients with Type 2 Diabetes Receiving Basal Insulin and Poor Glycemic Control (HbA1c >8%)—A Societal Perspective in Spain

July 16, 2025 by sugaradmin

Introduction and Objective: This cost analysis compared FreeStyle Libre® systems (FSL) vs self-monitoring of blood glucose (SMBG) in T2D patients on basal insulin and poorly controlled (HbA1c > 8%), from a societal perspective in Spain.Methods: A model compared costs (€2024) of FSL and SMBG in a cohort of 1,000 T2D patients. The inputs, validated by […]

Read More
DiabetesLeave a Comment on 1057-P: Cost Analysis of Freestyle Libre Systems in Patients with Type 2 Diabetes Receiving Basal Insulin and Poor Glycemic Control (HbA1c >8%)—A Societal Perspective in Spain

51-PUB: Prescription of Thyroid Hormone Replacement Therapy in Individuals with Diabetes in Spain—Differences by Sex, Age, and Temporal Trends (2018–2023)

July 16, 2025 by sugaradmin

Introduction and Objective: Diabetes mellitus (DM) is a chronic condition characterized by elevated blood glucose levels due to insufficient insulin production or ineffective utilization. DM often coexists with thyroid diseases, particularly hypothyroidism, which can impact glycemic control and increase the risk of complications. Thyroid replacement therapy, typically with levothyroxine, is crucial for managing hypothyroidism in […]

Read More
DiabetesLeave a Comment on 51-PUB: Prescription of Thyroid Hormone Replacement Therapy in Individuals with Diabetes in Spain—Differences by Sex, Age, and Temporal Trends (2018–2023)

36-OR: Sex-Based Molecular Architecture of Estrogen Receptor Actions in Human Islet Cells

July 16, 2025 by sugaradmin

Introduction and Objective: The main estrogen (17β-estradiol, E2) enhances insulin biosynthesis and secretion, protecting both female (F) and male (M) β-cells from metabolic stresses via the estrogen receptor-α (ERα). E2 activates unfolded protein degradation pathways, mitigating endoplasmic reticulum (EndRet) stress in human and mouse islets. However, the FDA-approved selective estrogen receptor modulator (SERM) bazedoxifene (BZA) […]

Read More
DiabetesLeave a Comment on 36-OR: Sex-Based Molecular Architecture of Estrogen Receptor Actions in Human Islet Cells

51-OR: Prognostic Proteomics Modeling in Type 2 Diabetes Reveals Shared and Distinct Mechanisms of Macro- and Microvascular Complications

July 16, 2025 by sugaradmin

Introduction and Objective: T2D complications manifest across various organs, but are fundamentally rooted in vascular dysfunction, including fibrosis, inflammation, calcification and endothelial damage. Much of complication heterogeneity arises from variation in angiostructures (e.g., larger vessels vs. smaller capillaries) and how they are impacted by elevated glucose levels. This study aims to identify mechanisms underlying macro- […]

Read More
DiabetesLeave a Comment on 51-OR: Prognostic Proteomics Modeling in Type 2 Diabetes Reveals Shared and Distinct Mechanisms of Macro- and Microvascular Complications

25-OR: N6-methyladenosine on Chromatin-Associated RNA (carRNA)—A Key Regulator of Transcription in Human Islets with Type 2 Diabetes

July 16, 2025 by sugaradmin

Introduction and Objective: Chromatin-associated regulatory RNAs (carRNAs), including promoter- and enhancer-associated RNAs, are known regulators of global gene transcription, yet the regulation of carRNAs remains poorly understood. Recent studies implicate RNA N6-methyladenosine (m6A) modification in carRNA stability and function. Seminal work from our lab has shown that m6A “writers” (e.g., methyltransferase-like 3 (METTL3) and METTL14) […]

Read More
DiabetesLeave a Comment on 25-OR: N6-methyladenosine on Chromatin-Associated RNA (carRNA)—A Key Regulator of Transcription in Human Islets with Type 2 Diabetes

Posts navigation

Older posts
Newer posts

Recent Posts

  • Why Are Some People Tastier Than Others
  • Bringing early detection to life: real-world operationalization of a presymptomatic type 1 diabetes screening and monitoring pilot program
  • Special Edition: Obesity Processes and PATHWEIGH for Obesity Care
  • Only 20% of Sunscreens Meet Safety Standards, Report Shows
  • ER Visit Numbers are Highest in Over 10 Years

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness